广州维力医疗器械股份有限公司 关于参与设立产业投资基金的进展公告

Group 1 - The company has signed a partnership agreement to establish a medical industry investment partnership named "Weizhi Medical Navigation (Suzhou) Medical Industry Investment Partnership (Limited Partnership)" with several investment entities, aiming to leverage professional investment resources for strategic development [2] - The company plans to contribute RMB 37.5 million, accounting for 25% of the total committed capital of RMB 150 million for the partnership [2] - The partnership has completed its business registration procedures as of June 24, 2025 [3] Group 2 - The partnership has successfully completed the private investment fund registration with the Asset Management Association of China, obtaining the private fund registration certificate on August 7, 2025 [4] - The fund is managed by Xianglv Venture Capital Management (Guangzhou) Co., Ltd., and the registration code is SBCS25 [4] - The company will closely monitor the operation of the investment fund and fulfill its information disclosure obligations as required by relevant laws and regulations [4]